fiftynin
men
mean
age
year
women
mean
age
year
recruit
octob
novemb
studi
etiolog
common
cold
criteria
inclus
presenc
acut
rhinorrhea
nasal
congest
andor
sore
throat
durat
recent
upper
respiratori
tract
infect
tonsil
histori
allerg
rhiniti
chronic
ill
use
regular
medic
reason
exclus
npa
collect
entri
studi
first
followup
visit
week
later
npa
kept
frozen
year
analyz
studi
antibodi
test
serum
sampl
obtain
studi
entri
week
later
kept
use
viru
propag
done
madindarbi
canin
kidney
cell
mdckin
provid
h
nishimura
yamagata
univers
school
medicin
yamagata
japan
cell
grown
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
bovin
serum
albumin
mm
hepe
antibiot
dmembsa
contain
fetal
bovin
serum
fb
influenza
cann
grown
mdckin
cell
use
dmembsa
supplement
chloromethyl
tpcktrypsin
five
day
inocul
medium
collect
clarifi
centrifug
store
aliquot
viru
stock
serv
posit
control
rtpcr
use
antibodi
assay
viral
rna
extract
npa
use
commerci
kit
nucleospin
viru
machereynagel
influenza
c
viru
rna
revers
transcrib
amplifi
separ
rtpcr
use
set
primer
pair
tabl
one
specif
hemagglutininesteras
fusion
protein
gene
hef
nonstructur
protein
gene
reaction
mixtur
contain
mm
dntp
finnzym
mm
pmol
forward
primer
also
prime
cdna
reaction
revers
primer
u
rnasin
promega
u
dna
polymeras
dynazym
finnzym
u
enzym
avian
myeloblastosi
viru
revers
transcriptas
promega
extract
rna
cdna
synthes
min
follow
incub
thereaft
cdna
amplifi
cycl
consist
denatur
primer
anneal
primer
extens
final
cycl
primer
extens
continu
min
rna
cann
serv
posit
control
run
reaction
tube
contain
water
instead
rna
includ
neg
control
amplifi
product
detect
electrophoresi
agaros
gel
ethidium
bromid
stain
immunoperoxidas
stain
assay
develop
detect
influenza
antibodi
microtit
plate
nunc
seed
mdckin
cell
approxim
cell
dmembsa
contain
fb
ad
well
plate
incub
humidifi
atmospher
cell
confluent
growth
medium
replac
dmembsa
contain
cann
tpcktrypsin
plate
centrifug
g
ambient
temperatur
min
incub
day
amount
viru
chosen
cell
becam
infect
cell
wash
pb
fix
aceton
pb
room
temperatur
min
wash
twice
pb
plate
kept
use
within
week
serum
sampl
dilut
pb
contain
nonfat
dri
milk
powder
pbsm
test
serial
dilut
start
known
posit
serum
sampl
fb
neg
control
includ
plate
serum
incub
done
min
well
wash
pb
peroxidaselabel
rabbit
antibodi
human
igg
dako
dilut
pbsm
ad
well
plate
incub
min
well
wash
trueblu
substrat
kirkegaard
perri
ad
well
min
well
rins
twice
pb
plate
read
invert
microscop
magnif
distinct
blue
cytoplasm
nuclear
stain
infect
cell
absenc
background
stain
uninfect
cell
consid
posit
result
increas
titer
acut
convalesc
serum
consid
signific
result
cann
detect
limit
rtpcr
protocol
primer
pair
hef
primer
respect
npa
collect
first
visit
show
distinct
band
appropri
size
primer
pair
tabl
patient
sampl
obtain
still
posit
pcr
first
control
visit
week
later
signal
detect
primer
pair
remain
patient
neg
pcr
result
initi
visit
second
npa
randomli
select
patient
initi
neg
pcr
result
also
test
pcr
none
yield
posit
signal
influenza
antibodi
detect
studi
particip
increas
acut
convalescentphas
serum
sampl
found
individu
pcrposit
result
tabl
addit
studi
particip
pcrneg
result
increas
titer
signific
fluctuat
antibodi
level
detect
remain
individu
pcrneg
result
influenza
c
case
occur
winter
spring
durat
ill
patient
pcrposit
result
vari
fever
day
durat
day
tabl
sinus
confirm
radiolog
individu
laboratori
evid
recent
infect
influenza
c
tabl
knowledg
first
success
attempt
detect
influenza
c
rna
clinic
specimen
mean
rtpcr
adult
common
cold
durat
diagnos
influenza
c
infect
specimen
patient
found
posit
rtpcr
specimen
found
posit
repeat
examin
pathogen
could
identifi
influenza
patient
result
shown
individu
pcrposit
result
increas
antibodi
titer
serum
sampl
collect
acut
convalesc
phase
ill
underlin
specif
pcr
result
addit
studi
particip
pcrneg
result
also
signific
increas
antibodi
titer
patient
tabl
titer
found
first
serum
sampl
patient
high
convalescentphas
serum
sampl
patient
pcrposit
result
howev
observ
period
patient
show
increas
antibodi
titer
influenza
c
patient
also
signific
titer
increas
coronaviru
result
shown
person
possibl
experienc
influenza
c
infect
week
earlier
enter
studi
acut
infect
coronaviru
laboratorygrown
viru
materi
sensit
pcr
rel
low
howev
signific
increas
antibodi
titer
accept
definit
proof
recent
infect
viru
diagnost
sensit
pcr
assay
satisfactori
prolong
storag
npa
repeat
freez
thaw
evid
affect
abil
detect
virusspecif
gene
sequenc
specimen
npa
obtain
patient
result
first
control
visit
week
studi
entri
also
test
one
patient
still
pcrposit
result
indic
viru
rapidli
clear
upper
respiratori
tract
furthermor
patient
also
longer
durat
fever
ill
influenza
patient
patient
tabl
although
rtpcr
may
rather
sophist
techniqu
diagnos
rel
benign
respiratori
viru
antibodi
assay
describ
easi
perform
allow
simultan
test
numer
specimen
intens
nuclear
stain
infect
cell
indic
assay
predominantli
measur
antibodi
nucleoprotein
matrix
protein
contrast
strainspecif
hemagglutin
inhibit
hi
test
measur
antibodi
hef
influenza
b
nucleoprotein
matrix
protein
influenza
c
viru
well
preserv
evolut
thu
offer
reliabl
sourc
antigen
absenc
recent
isol
could
use
hi
test
earlier
studi
eia
shown
sensit
hi
test
detect
titer
increas
studi
antigen
probabl
consist
mainli
nucleoprotein
matrix
protein
none
patient
seroneg
influenza
c
accord
anoth
studi
high
seropreval
antibodi
titer
found
adult
mean
eia
howev
epidemiolog
studi
franc
found
seroposit
rate
age
group
reflect
studi
popul
author
studi
use
highli
purifi
viru
antigen
eia
remain
unclear
signific
fraction
studi
popul
lack
antibodi
influenza
c
like
viru
caus
acut
upper
respiratori
tract
infect
adult
would
readili
effici
infect
suscept
younger
individu
therefor
antibodi
detect
virtual
adult
evid
influenza
c
patient
experienc
reinfect
viru
influenza
case
occur
decemb
may
howev
number
posit
find
small
draw
conclus
epidemiolog
season
viru
recent
studi
israel
case
influenza
c
identifi
outbreak
influenza
b
winter
common
cold
ill
viral
etiolog
studi
viral
caus
establish
patient
wherea
evid
bacteri
infect
found
patient
yet
larg
proport
patient
common
cold
seek
medic
attent
receiv
antibiot
treatment
sinus
frequent
complic
common
cold
consid
bacteri
origin
recent
studi
though
patient
acut
sinus
connect
common
cold
lack
laboratori
paramet
indic
bacteri
infect
better
understand
common
cold
etiolog
accumul
inform
inflammatori
process
caus
characterist
symptom
may
result
ration
use
exist
drug
acceler
research
toward
new
therapeut
intervent
incid
studi
influenza
c
caus
mani
case
common
cold
parainfluenza
virus
mani
episod
adenovirus
respiratori
syncyti
viru
enterovirus
combin
equal
number
case
bacteri
pathogen
chlamydia
pneumonia
mycoplasma
pneumonia
streptococcu
pneumonia
haemophilu
influenza
find
indic
influenza
c
relev
pathogen
caus
acut
respiratori
infect
